Anaphylactic shock decreases cerebral blood flow more than what would be expected from severe arterial hypotension

Shock

Volumn 38, Issue 4, 2012, Pages 429-435

  Davidson, Julien ^a   Zheng, Feng ^a   Tajima, Keiko ^a   Barthel, Grégoire ^a   Alb, Ionel ^a,b   Tabarna, Adriana ^a,b   Thornton, Simon N ^a   Lambert, Maud ^a   Longrois, Dan ^c   Audibert, Gérard ^a,b   Malinovsky, Jean Marc ^a,d   Mertes, Paul Michel ^a,e  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c BICHAT HOSPITAL   (France)

^d REIMS UNIVERSITY HOSPITAL   (France)

^e UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

anaphylaxis; autoregulation; cerebrovascular circulation; Shock

Indexed keywords

HEMOGLOBIN; LACTIC ACID; NICARDIPINE; OVALBUMIN;

ANAPHYLACTIC SHOCK; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD PRESSURE; BRAIN BLOOD FLOW; BRAIN CIRCULATION; BRAIN TISSUE; CAROTID ARTERY FLOW; CONTROLLED STUDY; DISEASE SEVERITY; HEART OUTPUT; HYPOTENSION; MALE; MEAN ARTERIAL PRESSURE; NONHUMAN; OXYGENATION; RAT; RESUSCITATION; TISSUE OXYGENATION;

ANAPHYLAXIS; ANIMALS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CAROTID ARTERIES; CEREBROVASCULAR CIRCULATION; INTRACRANIAL HYPOTENSION; MALE; NICARDIPINE; RATS; RESUSCITATION; VASODILATOR AGENTS;

EID: 84866608704     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e3182690897     Document Type: Article

References (35)

1. Sampson HA, Munoz-Furlong A, Campbell RL, Adkinson NF Jr, Bock SA, Branum A, Brown SG, Carmago CA Jr, Cydulka R, Galli SJ, et al.: Second symposium on the definition and management of anaphylaxis: summary reportVSecond National Institute of Allergy and Infectious Disease/Food Allergy and Anaphylaxis Network symposium. J Allergy Clin Immunol 117(2): 391-397, 2006.
2. Lieberman P, Camargo CA Jr, Bohlke K, Jick H, Miller RL, Sheikh A, Simons FE: Epidemiology of anaphylaxis: findings of the American College of Allergy, Asthma and Immunology Epidemiology of Anaphylaxis Working Group. Ann Allergy Asthma Immunol 97(5):596-602, 2006.
3. Sheikh A, Shehata YA, Brown SG, Simons FE: Adrenaline (epinephrine) for the treatment of anaphylaxis with and without shock. Cochrane Database Syst Rev 8(4):CD006312, 2008.
4. Brown SG: Anaphylaxis: clinical concepts and research priorities. Emerg Med Australas 18(2):155-169, 2006.
5. Ogoh S, Ainslie PN: Cerebral blood flow during exercise: mechanisms of regulation. J Appl Physiol 107(5):1370-1380, 2009.
6. van Beek AH, Claassen JA, Rikkert MG, Jansen RW: Cerebral autoregulation: an overview of current concepts and methodology with special focus on the elderly. J Cereb Blood Flow Metab 28(6):1071-1085, 2008.
7. Rudzinski W, Swiat M, Tomaszewski M, Krejza J: Cerebral hemodynamics and investigations of cerebral blood flow regulation. Nucl Med Rev Cent East Eur 10(1):29-42, 2007.
8. Czosnyka M, Brady K, Reinhard M, Smielewski P, Steiner LA: Monitoring of cerebrovascular autoregulation: facts, myths, and missing links. Neurocrit Care 10(3):373-386, 2009.
9. Dewachter P, Jouan-Hureaux V, Franck P, Menu P, de Talance N, Zannad F, Laxenaire MC, Longrois D, Mertes PM: Anaphylactic shock: a form of distributive shock without inhibition of oxygen consumption. Anesthesiology 103(1):40-49, 2005.
10. Bellou A, Lambert H, Gillois P, Montemont C, Gerard P, Vauthier E, Sainte-Laudy J, Longrois D, Guéant JL, Mallié JP: Constitutive nitric oxide synthase inhibition combined with histamine and serotonin receptor blockade improves the initial ovalbumin-induced arterial hypotension but decreases the survival time in brown norway rats anaphylactic shock. Shock 19(1):71-78, 2003.
11. Knippels LM, Penninks AH, Smit JJ, Houben GF: Immune-mediated effects upon oral challenge of ovalbumin-sensitized Brown Norway rats: further characterization of a rat food allergy model. Toxicol Appl Pharmacol 156(3):161-169, 1999.
12. Hysing ES, Chelly JE, Douroul MF, Hartley C, Merin RG: Cardiovascular effects of and interaction between calcium blocking drugs and anesthetics in chronically instrumented dogs. III. Nicardipine and isoflurane. Anesthesiology 65(4):385-391, 1986.
13. Dewachter P, Jouan-Hureaux V, Lartaud I, Bello G, de Talance N, Longrois D, Mertes PM: Comparison of arginine vasopressin, terlipressin, or epinephrine to correct hypotension in a model of anaphylactic shock in anesthetized brown Norway rats. Anesthesiology 104(4):734-741, 2006.
14. Dewachter P, Raeth-Fries I, Jouan-Hureaux V, Menu P, Vigneron C, Longrois D, Mertes PM: A comparison of epinephrine only, arginine vasopressin only, and epinephrine followed by arginine vasopressin on the survival rate in a rat model of anaphylactic shock. Anesthesiology 106(5):977-983, 2007.
15. Pumphrey RS: Fatal posture in anaphylactic shock. J Allergy Clin Immunol 112(2):451-452, 2003.
16. Barbiro-Michaely E, Tolmasov M, Rinkevich-Shop S, Sonn J, Mayevsky A: Can the Bbrain-sparing effect be detected in a small-animal model? Med Sci Monit 13(10):BR211-BR219, 2007.
17. Brown SG: The pathophysiology of shock in anaphylaxis. Immunol Allergy Clin North Am 27(2):165-175, 2007.
18. 3 receptor blockade improves cardiac function in canine anaphylaxis. Am J Respir Crit Care Med 160(4):1142-1149, 1999.
19. Mitsuhata H, Takeuchi H, Saitoh J, Hasome N, Horiguchi Y, Shimizu R: An inhibitor of nitric oxide synthase, N-omega-nitro-L-arginine-methyl ester, attenuates hypotension but does not improve cardiac depression in anaphylaxis in dogs. Shock 3(6):447-454, 1995.
20. Hiruta A, Mitsuhata H, Hiruta M, Horikawa Y, Takeuchi H, Kawakami T, Saitoh J, Seo N: Vasopressin may be useful in the treatment of systemic anaphylaxis in rabbits. Shock 24(3):264-269, 2005.
21. Cui S, Shibamoto T, Zhang W, Takano H, Kurata Y: Venous resistance increases during rat anaphylactic shock. Shock 29(6):733-739, 2008.
22. Liu W, Takano H, Shibamoto T, Cui S, Zhao ZS, Zhang W, Kurata Y: Involvement of splanchnic vascular bed in anaphylactic hypotension in anesthetized BALB/c mice. Am J Physiol Regul Integr Comp Physiol 293(5):R1947-R1953, 2007.
23. Karasawa N, Shibamoto T, Cui S, Takano H, Kurata Y, Tsuchida H: Hepatic pre-sinusoidal vessels contract in anaphylactic hypotension in rabbits. Acta-Physiol (Oxford) 189(1):15-22, 2007.
24. Fox AJ, McLaren IM, Naylor AR: Cerebral perfusion monitored using trans-cranial Doppler during acute anaphylaxis. Anaesthesia 54(7):678-682, 1999.
25. Kapin MA, Law WR, Raymond RM, Ferquson JL: The cerebral circulatory response during caine anaphylactic shock. Circ Shock 20(2):115-125, 1986.
26. Wan Z, Ristagno G, Sun S, Li Y, Weil MH, Tang W: Preserved cerebral microcirculation during cardiogenic shock. Crit Care Med 37(8):2333-2337, 2009.
27. Wan Z, Sun S, Ristagno G, Weil MH, Tang W: The cerebral microcirculation is protected during experimental hemorrhagic shock. Crit Care Med 38(3): 928-932, 2010.
28. Taccone FS, Su F, Pierrakos C, He X, James S, Dewitte O, Vincent JL, De Backer D: Cerebral microcirculation is impaired during sepsis: an experimental study. Crit Care 14(4):R140, 2010.
29. Vadas P, Gold M, Perelman B, Liss GM, Lack G, Blyth T, Simons FE, Simons KJ, Cass D, Yeung J: Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 358(1):28-35, 2008.
30. Cauwels A: Nitric oxide in shock. Kidney Int 72(5):557-565, 2007.
31. Wahl M, Schilling L: Regulation of cerebral blood flowVa brief review. Acta Neurochir Suppl (Wien) 59:3-10, 1993.
32. Lindsberg PJ, Strbian D, Karjalainen-Lindsberg ML: Mast cells as early res-ponders in the regulation of acute blood-brain barrier changes after cerebral ischemia and hemorrhage. J Cereb Blood Flow Metab 30(4):689-702, 2010.
33. Cauwels A, Janssen B, Buys E, Sips P, Brouckaert P: Anaphylactic shock depends on PI3K and eNOS-derived NO. J Clin Invest 116(8):2244-2251, 2006.
34. Kochanek PM, Nemoto EM, Melick JA, Evans RW, Burke DF: Cere-brovascular and cerebrometabolic effects of intracarotid infused platelet-activating factor in rats. J Cereb Blood Flow Metab 8(4):546-551, 1988.
35. Dunser MW, Torgersen C, Wenzel V: Treatment of anaphylactic shock: where is the evidence? Anesth Analg 107(2):359-361, 2008.